Skip to main content
. Author manuscript; available in PMC: 2014 Sep 2.
Published in final edited form as: Epilepsia. 2010 Sep;51(9):1714–1720. doi: 10.1111/j.1528-1167.2010.02545.x

Table 1.

Summary of microarray results in three regions of rat brain after chronic treatment with levetiracetam (Levet) or phenytoin (Phen)

Drug Region No. expressed transcripts No. transcripts with mean
>150% or <67% of control
No. transcripts
>150%or <67% of control and FDR < 0.01
Levet Pons/medulla 9,765 114 65
Phen Pons/medulla 9,861   45   3
Levet Hippocampus 9,507   48   2
Phen Hippocampus 9,938 223 64
Levet Frontal cortex 9,771   75   1
Phen Frontal cortex 9,898 496 327

The rat 230.2 GeneChip was used, which contained probe sets representing 16,165 unique transcripts (Dai et al., 2005). Each row represents data from 6 to 7 control or drug-treated animals. The third column shows the number of expressed transcripts with above-background signals in all or all but one control or drug-treated animals. The fourth column shows the number of transcripts with expression >150% or <67% of control as calculated from mean values, whereas the fifth column shows the number of differentially expressed transcripts after controlling for a false discovery rate (FDR) of <0.01 [one-way analysis of variance (ANOVA) with Benjamini and Hochberg (1995) correction for multiple comparisons].